Pure Global AI
ANVISA RDC

RDC 777/2023

RDC 777/2023 — amendment to RDC 751/2022
BrazilANVISARegistrationCurrentness under reviewEffective March 1, 2023
Official source linked
Document status

Currentness under review. Whether this instrument remains applicable is under review. Consult the later instruments and source context below before relying on it.

What this code is

RDC 777/2023 is ANVISA Collegiate Board Resolution 777/2023. A Collegiate Board Resolution is ANVISA’s primary binding regulation. The number is sequential within the year (RDC 751/2022 is resolution 751 issued in 2022).

Instrument
RDC
Full name
Resolução da Diretoria Colegiada
Category
Registration
Source links
Source publication
Portuguese
Open the source text
Linked source text; confirm the publisher, publication details and any later amendment or consolidated version.
Readable HTML
1 language version
Read the full text →
Direct citations can link to a specific article or section by appending its fragment identifier.
Dates
Published
March 1, 2023
Effective
March 1, 2023
Readable full text

Open a language version

Each version has stable passage anchors for direct citations and highlighting. The readable text is generated from an authority source and does not replace the legally controlling publication.

Portuguese full textPortuguese — official original textRead HTML →
About this regulation

RDC 777/2023 — amendment to RDC 751/2022

Complete two-page official Espírito Santo health-secretariat hosted expression of ANVISA RDC 777/2023, amending the medical-device RDC 751/2022. The Annex II grid and publisher disclaimer are retained. The federal DOU publication controls; this MD amendment does not establish IVD rules or later currentness.

A Collegiate Board Resolution is ANVISA’s primary binding regulation. The number is sequential within the year (RDC 751/2022 is resolution 751 issued in 2022). Always confirm the current consolidated text and transition provisions with the official source before filing.

Source linked